Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo

Elife. 2020 Aug 10:9:e58463. doi: 10.7554/eLife.58463.

Abstract

T regulatory (Treg) cells play vital roles in modulating immunity and tissue homeostasis. Their actions depend on TCR recognition of peptide-MHC molecules; yet the degree of peptide specificity of Treg-cell function, and whether Treg ligands can be used to manipulate Treg cell biology are unknown. Here, we developed an Ab-peptide library that enabled unbiased screening of peptides recognized by a bona fide murine Treg cell clone isolated from the visceral adipose tissue (VAT), and identified surrogate agonist peptides, with differing affinities and signaling potencies. The VAT-Treg cells expanded in vivo by one of the surrogate agonists preserved the typical VAT-Treg transcriptional programs. Immunization with this surrogate, especially when coupled with blockade of TNFα signaling, expanded VAT-Treg cells, resulting in protection from inflammation and improved metabolic indices, including promotion of insulin sensitivity. These studies suggest that antigen-specific targeting of VAT-localized Treg cells could eventually be a strategy for improving metabolic disease.

Keywords: Treg cells; adipose tissue; immunology; inflammation; mouse; surrogate antigens.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • HEK293 Cells
  • Humans
  • Inflammation / metabolism*
  • Insulin Resistance / physiology*
  • Intra-Abdominal Fat / metabolism*
  • Jurkat Cells
  • K562 Cells
  • Male
  • Mice
  • Mice, Transgenic
  • Peptide Library
  • T-Lymphocytes, Regulatory / physiology*

Substances

  • Peptide Library

Associated data

  • GEO/GSE151070
  • GEO/GSE150173